Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock

Anesthesiology

Volumn 107, Issue 2, 2007, Pages 273-280

  Hermann, Joerg ^b   Corso, Carlos ^b   Messmer, Konrad F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN 60; NITRIC OXIDE; RECOMBINANT HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CAPILLARY DENSITY; COLLOID; CONTROLLED STUDY; DISEASE MODEL; HAMSTER; HEMODYNAMICS; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MICROSCOPY; MICROVASCULATURE; NONHUMAN; ONCOTIC PRESSURE; PRIORITY JOURNAL; RESUSCITATION; SKINFOLD THICKNESS; WILD TYPE;

ACIDOSIS; ANIMALS; ANTICOAGULANTS; BLOOD PRESSURE; BLOOD SUBSTITUTES; CRICETINAE; DEXTRANS; DISEASE MODELS, ANIMAL; HEMOGLOBINS; HEMOGLOBINS, ABNORMAL; MICROCIRCULATION; MUSCLE, SKELETAL; NITRIC OXIDE; RECOMBINANT PROTEINS; RESUSCITATION; SHOCK, HEMORRHAGIC; VASOCONSTRICTION;

EID: 34547600479     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000270756.11669.64     Document Type: Article

References (44)

1. Messmer K, Kreimeier U: Microcirculatory therapy in shock. Resuscitation 1989; 18 (suppl):51-61
2. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV: Outcome after hemorrhagic shock in trauma patients. J Trauma 1998; 45:545-9
3. Paxian M, Rensing H, Geckeis K, Bauer I, Kubulus D, Spahn DR, Bauer M: Perflubron emulsion in prolonged hemorrhagic shock: Influence on hepatocellular energy metabolism and oxygen-dependent gene expression. ANESTHESIOLOGY 2003; 98:1391-9
4. Hess JR, MacDonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74:1769-78
5. Nolte D, Botzlar A, Pickelmann S, Bouskela E, Messmer K: Effects of diaspirin-cross-linked hemoglobin (DCLHb) on the microcirculation of striated skin muscle in the hamster: A study on safety and toxicity. J Lab Clin Med 1997; 130:314-27
6. Revell M, Greaves I, Porter K: Endpoints for fluid resuscitation in hemorrhagic shock. J Trauma 2003; 54:63-7
7. Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, Lemon DD: Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998; 16:672-6
8. Alayash AI: Hemoglobin-based blood substitutes: Oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 1999; 17:545-9
9. Doyle MP, Apostol I, Kerwin BA: Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. J Biol Chem 1999; 274:2583-91
10. Malhotra AK, Kelly ME, Miller PR, Hartman JC, Fabian TC, Proctor KG: Resuscitation with a novel hemoglobin-based oxygen carrier in a swine model of uncontrolled perioperative hemorrhage. J Trauma 2003; 54:915-24
11. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, Miller-Roehrich J, Shoemaker S, Trimble S, Fermi G: A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992; 19:356:258-60
12. Burhop KE, Doyle MP: The development and preclinical testing of a second-generation recombinant hemoglobin solution, rHb2.0 for injection, Microcirculatory Effects of Hemoglobin Solutions. Progress in Applied Microcirculation. Vol 25. Edited by Messmer K, Burhop KE, Hutter J. Basel, Karger, 2004, pp 48-64
13. Endrich B, Asaishi K, Götz A, Messmer K: Technical report- a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980; 177:125-34
14. Nolte D, Zeintl H, Steinbauer M, Pickelmann S, Messmer K: Functional capillary density: An indicator of tissue perfusion? Int J Microcirc Clin Exp 1995; 15:244-9
15. Lindbom L, Arfors KE: Mechanisms and site of control for variation in the number of perfused capillaries in skeletal muscle. Int J Microcirc Clin Exp 1985; 4:19-30
16. Messmer K, Lewis DH, Sunder-Plassmann L, Klövekorn WP, Mendler N, Holper K: Acute normovolemic hemodilution: Changes of central hemodynamics and microcirculatory flow in skeletal muscle. Eur Surg Res 1972; 4:55-70
17. Menger MD, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of "no reflow." Am J Physiol 1992; 263:H1892-900
18. Klyscz T, Jünger M, Jung F, Zeintl H: Cap Image-ein neuartiges computer-unterstütztes Videobildanalysesystem für die dynamische Kapillarmikroskopie. Biomed Tech (Berl) 1997; 42:168-75
19. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD: Epidemiology of trauma deaths. Am J Surg 1980; 140:144-50
20. Kerger H, Waschke KF, Ackern KV, Tsai AG, Intaglietta M: Systemic and microcirculatory effects of autologous whole blood resuscitation in severe hemorrhagic shock. Am J Physiol 1999; 276:H2035-43
21. Meisner FG, Kemming GI, Habler OP, Kleen MS, Tillmanns JH, Hutter JW, Bottino DA, Thein E, Meier JM, Wojtczyk CJ, Pape A, Messmer K: Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Crit Care Med 2001; 29:829-38
22. Siegel JH, Fabian M, Smith JA, Costantino D: Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 1997; 42:199-212
23. Schultz SC, Hamilton IN Jr, Malcolm DS: Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 1993; 35:619-25
24. Loeb AL, McIntosh LJ, Raj NR, Longnecker DE: Resuscitation after hemorrhage using recombinant human hemoglobin (rHb1.1) in rats: Effects on nitric oxide and prostanoid systems. Crit Care Med 1998; 26:1071-80
25. Botzlar A, Nolte D, Messmer K: Effects of ultra-purified polymerized bovine hemoglobin on the microcirculation of striated skin muscle in the hamster. Eur J Med Res 1996; 1:471-8
26. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. JAMA 1999; 282:1857-64
27. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U: DCL-Hb for trauma patients with severe hemorrhagic shock: The European "On-Scene" Multicenter Study. Intensive Care Med 2003; 29:378-85
28. Sloan EP, Koenigsberg M, Brunett PH, Bynoe RP, Morris JA, Tinkoff G, Dalsey WC, Ochsner MG: Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock. J Trauma 2002; 52:887-95
29. Riou B, Landais P, Vivien B, Stell P, Labbene I, Carli P: Distribution of the probability of survival is a strategic issue for randomized trials in critically ill patients. ANESTHESIOLOGY 2001; 95:56-63
30. Winslow RM: αα-Crosslinked hemoglobin: Was failure predicted by preclinical testing? Vox Sang 2000; 79:1-20
31. Capone AC, Safar P, Stezoski W, Tisherman S, Peitzman AB: Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J Am Coll Surg 1995; 180:49-56
32. von Dobschütz E, Hutter J, Hoffmann T, Messmer K: Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock. ANESTHESIOLOGY 2004; 100:1484-90
33. Raat NJ, Liu JF, Doyle MP, Burhop KE, Klein J, Ince C: Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J Lab Clin Med 2005; 145:21-32
34. Dunham CM, Siegel JH, Weireter L, Fabian M, Goodarzi S, Guadalupi P, Gettings L, Linberg SE, Vary TC: Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med 1991; 19:231-43
35. Rutherford EJ, Morris JA Jr, Reed GW, Hall KS: Base deficit stratifies mortality and determines therapy. J Trauma 1992; 33:417-23
36. Kerger H, Tsai AG, Saltzman DJ, Winslow RM, Intaglietta M: Fluid resuscitation with O2 versus non-O2 carriers after 2 h of hemorrhagic shock in conscious hamsters. Am J Physiol 1997; 272:H525-37
37. Bergentz SE, Carlsten A, Gelin LE, Krebs J: Hidden acidosis in experimental shock. Ann Surg 1969; 169:227-32
38. Baldwin AL: Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery. Am J Physiol 1999; 277:H650-9
39. Dull RO, DeWitt BJ, Dinavahi R, Schwartz L, Hubert C, Pace N, Fronticelli C: Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J Appl Physiol 2004; 97:1930-7
40. Caron A, Mayer JC, Menu P, Alayash A, Marie PY, Vigneron C: Measurement of blood volume after haemodilution with haemoglobin-based oxygen carriers by a radiolabelled-albumin method. Transfus Med 2001; 11:433-42
41. Migita R, Gonzales A, Gonzales ML, Vandegriff KD, Winslow RM: Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 1997; 82:1995-2002
42. Kavdia M, Tsoukias NM, Popel AS: Model of nitric oxide diffusion in an arteriole: Impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol 2002; 282:H2245-53
43. Tsai AG, Friesenecker B, McCarthy M, Sakai H, Intaglietta M: Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 1998; 275:H2170-80
44. Resta TC, Walker BR, Eichinger MR, Doyle MP: Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 2002; 93:1327-36